Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00692484 · ClinicalTrials.gov registry record · Phase 3
Pilot Evaluation of the Application Procedure on the Antimicrobial Effects of 2 Antiseptics
A Phase 3 study, sponsored by C. R. Bard.
- Completed
- Registry status
- Phase 3
- Development phase
- 122
- Enrollment target
NCT00692484 is a Phase 3 study that has completed, run by C. R. Bard. The registered enrollment target is 122 participants.
The verdict
NCT00692484, a Phase 3 study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 122 participants
- Enrollment target
Study Summary
Evaluate effect of application procedure on efficacy of 2 antiseptics for cleaning skin prior to surgery.
Interventions
- DRUG Chlorhexidine gluconate
- DRUG Povidone iodine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00692484
The ClinicalTrials.gov registry entry for NCT00692484 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Chlorhexidine gluconate is the first listed.
NCT00692484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00692484 about?
NCT00692484 is a clinical study titled "Pilot Evaluation of the Application Procedure on the Antimicrobial Effects of 2 Antiseptics". Evaluate effect of application procedure on efficacy of 2 antiseptics for cleaning skin prior to surgery.
What is the current status of trial NCT00692484?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 122 participants. The study started on 2007-10. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00692484?
The interventions under investigation include: Chlorhexidine gluconate (DRUG), Povidone iodine (DRUG).
Who is sponsoring clinical trial NCT00692484?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.